Search research articles
Contact Us
Filters
Showing results (221-230 of 420) with videos related to
Page
of 42
Sort By:
The Journal of Antimicrobial Chemotherapy
|
February 17, 2009
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
Ronald N Jones, Gary J Moet, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
July 12, 2015
Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014)
Helio S Sader, Mariana Castanheira, David J Farrell, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 13, 2019
Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America
Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy
|
January 11, 2012
Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections
Helio S Sader, Douglas J Biedenbach, Susanne Paukner, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 2014
Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012
Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Journal of Clinical Microbiology
|
August 11, 2017
Determination of Disk Diffusion and MIC Quality Control Guidelines for High-Dose Cefepime-Tazobactam (WCK 4282), a Novel Antibacterial Combination Consisting of a β-Lactamase Inhibitor and a Fourth-Generation Cephalosporin
Stefan Riedel, Michael D Huband, Helio S Sader, et al.
Journal of Global Antimicrobial Resistance
|
July 24, 2017
Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015)
Michael A Pfaller, Rodrigo E Mendes, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy
|
March 8, 2019
Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016)
Helio S Sader, Mariana Castanheira, S J Ryan Arends, et al.
The Journal of Antimicrobial Chemotherapy
|
July 27, 2022
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19)
Helio S Sader, Rodrigo E Mendes, Leonard R Duncan, et al.
Open Forum Infectious Diseases
|
February 27, 2023
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019-2021)
Helio S Sader, Rodrigo E Mendes, Cecilia G Carvalhaes, et al.
Page
of 42
Search research articles
Search
Showing results (221-230 of 420) with videos related to
Sort By:
Page
of 42
The Journal of Antimicrobial Chemotherapy
|
February 17, 2009
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
Ronald N Jones, Gary J Moet, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
July 12, 2015
Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014)
Helio S Sader, Mariana Castanheira, David J Farrell, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 13, 2019
Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America
Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy
|
January 11, 2012
Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections
Helio S Sader, Douglas J Biedenbach, Susanne Paukner, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 2014
Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012
Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Journal of Clinical Microbiology
|
August 11, 2017
Determination of Disk Diffusion and MIC Quality Control Guidelines for High-Dose Cefepime-Tazobactam (WCK 4282), a Novel Antibacterial Combination Consisting of a β-Lactamase Inhibitor and a Fourth-Generation Cephalosporin
Stefan Riedel, Michael D Huband, Helio S Sader, et al.
Journal of Global Antimicrobial Resistance
|
July 24, 2017
Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015)
Michael A Pfaller, Rodrigo E Mendes, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy
|
March 8, 2019
Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016)
Helio S Sader, Mariana Castanheira, S J Ryan Arends, et al.
The Journal of Antimicrobial Chemotherapy
|
July 27, 2022
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19)
Helio S Sader, Rodrigo E Mendes, Leonard R Duncan, et al.
Open Forum Infectious Diseases
|
February 27, 2023
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019-2021)
Helio S Sader, Rodrigo E Mendes, Cecilia G Carvalhaes, et al.
Page
of 42